Skip to main content

Day: September 22, 2020

Sirios intersects 10.3 g/t Au over 2.9 m on the Aquilon gold property, Eeyou Istchee James Bay, Quebec, Canada

MONTREAL, Sept. 22, 2020 (GLOBE NEWSWIRE) — Management of SIRIOS RESOURCES INC. (TSX-V: SOI) is pleased to announce assay results from the seven drill holes completed last July on the Aquilon gold property at Eeyou Istchee James Bay, Quebec. More than thirty high-grade surface gold showings occur on this property, including some with spectacular gold grades (ref.: 12/02/2014; 01/01/2011; 06/26/2008 Press Releases). Numerous shallow drill holes were completed on the property over the years (205 holes totaling 12,247 m), with the majority of this work concentrated on four of the showings when the project was managed by its partners. Sirios reacquired full ownership of Aquilon in 2016, at which point they initiated and continue to revise the exploration strategy on this property, which is ranked internally as having an excellent discovery...

Continue reading

Sirios recoupe 10,3 g/t Au sur 2,9 mètres sur la propriété aurifère Aquilon, Eeyou Istchee Baie-James, Québec, Canada

MONTRÉAL, 22 sept. 2020 (GLOBE NEWSWIRE) — Les dirigeants de RESSOURCES SIRIOS INC. (TSX-V: SOI) ont le plaisir d’annoncer les résultats d’analyse des sept sondages complétés en juillet dernier sur la propriété aurifère Aquilon, à Eeyou Istchee Baie-James au Québec. Cette propriété comprend en surface plus d’une trentaine d’indices à haute teneur en or incluant certains avec des teneurs spectaculaires (réf. : communiqués 02/12/2014; 01/01/2011; 26/06/2008). Elle a fait l’objet de nombreux sondages au cours des années, toutefois la grande majorité de ceux-ci étaient très courts (205 sondages totalisant 12 247 mètres) et concentrés de façon très restreinte sur quatre indices lorsque le projet était dirigé par des partenaires. Sirios a récupéré 100% de cette propriété en 2016 et a entrepris alors et continue de repenser l’approche...

Continue reading

Draper Esprit VCT plc – Result of AGM

Draper Esprit VCT plcLegal Entity Identifier: 2138003I9Q1QPDSQ9Z97Result of AGM22 September 2020At the Annual General Meeting (“AGM”), of Draper Esprit VCT plc held on 22 September 2020, which was held as a closed meeting, all resolutions were passed.Details of the proxy votes in respect of the resolutions passed at the AGM received as at 11:00am on 18 September 2020, 48 hours before the time of the meeting (excluding weekends), at the receiving agent, Downing LLP, are set out below:A copy of the resolutions passed will be submitted to the National Storage Mechanism and will shortly be available for inspection athttps://data.fca.org.uk/#/nsm/nationalstoragemechanismThe Company decided to hold its AGM as a closed meeting because of the practical difficulties in holding open meetings with the ongoing social distancing restrictions. The board...

Continue reading

Influence+United welcomes Buzzoole

Naples, Italy, Sept. 22, 2020 (GLOBE NEWSWIRE) — Influence+United charter member, IZEA Worldwide, Inc. (NASDAQ: IZEA), today welcomed the leading influencer marketing company in Europe, Buzzoole, to the fast-growing, global alliance.Founded in 2013 and headquartered in the growing tech center of Naples, Italy, Buzzoole serves over 850 European Union brand partners and boasts the largest opt-in community of more than 260,000 creators.“With a population of nearly a half-billion people filled with rich and diverse cultural backgrounds, the influencer marketing industry across the E.U. stands to be one of advertising’s greatest game-changers,” said Ted Murphy, IZEA Chairman and Chief Executive Officer. “Influence+United was formed with the vision of bringing together the best providers around the world. We are thrilled to be partnering...

Continue reading

Cartier presents the strong hoisting capabilities of the shaft on the Chimo Mine Property

Highlights:With simple adjustments, the shaft on the Chimo Mine Property could extract 1.7 million metric tons per year (4,921 mt/day).This study is one of four engineering studies carried out in tandem with a preparatory study for a new mineral resource estimate on the Chimo Mine Property to reveal its full value.VAL-D’OR, Québec, Sept. 22, 2020 (GLOBE NEWSWIRE) — Cartier Resources Inc. (TSX-V: ECR) (“Cartier”) reports the results of an engineering study on the hoisting capacity of the underground mining infrastructure on the Chimo Mine Property. This property, owned 100% by Cartier, is located 45 km east of the Val-d’Or mining camp.The study reveals that the components of the internal shaft structure could be used to hoist skips with a loading capacity of 20 metrics tonnes each, travelling at a cruising speed of 2,200 feet/minute...

Continue reading

Cartier présente les fortes capacités de hissage du puits de la propriété Mine Chimo

Faits saillants :Avec de simples adaptations, 1,7 millions de tonnes métriques par année (4 921 tm/jr) pourraient être extraites par le puits de la propriété Mine Chimo.Les résultats de cette étude s’inscrivent dans le cadre de 4 études d’ingénierie en cours ainsi que d’une étude préparatoire à la réalisation d’une nouvelle estimation des ressources de la propriété Mine Chimo afin d’en révéler sa pleine valeur.VAL-D’OR, Québec, 22 sept. 2020 (GLOBE NEWSWIRE) — Ressources Cartier Inc. (TSX-V: ECR) (“Cartier”) rapporte les résultats d’une étude d’ingénierie sur les capacités de hissage de l’infrastructure minière souterraine de la propriété Mine Chimo. Cette propriété, dont les intérêts sont détenus à 100% par Cartier, est située à 45 km à l’Est du camp minier de Val-d’Or.L’étude révèle que les composantes de la structure interne...

Continue reading

Brazil Approves RedHill Biopharma’s Phase 2/3 COVID-19 Study with Opaganib

The ongoing global Phase 2/3 study with orally-administered opaganib in patients with severe COVID-19 is approved in Italy, the UK, Russia, Israel, Mexico and Brazil; 16 clinical sites initiated globally to date—In parallel, the opaganib U.S. Phase 2 study, with 8 active clinical sites, is approximately 75% enrolled and expected to be completed in the coming weeks—Opaganib completely inhibited SARS-CoV-2 viral replication in an in vitro human lung cell model, comparing favorably with remdesivir, the positive control in the study—Opaganib demonstrated dual anti-inflammatory and antiviral activity and targets a host cell component, unaffected by viral mutation, thus minimizing the likelihood of resistance—Global emergency use authorization applications planned, subject to positive clinical resultsTEL AVIV, Israel...

Continue reading

PyroGenesis Unveils Strategy to Become Global On-Site Dross Processor Delivering Zero-Landfill/Reduced Carbon Solution; Reduces GHG Emissions; Provides General DROSRITE™ Update

MONTREAL, Sept. 22, 2020 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, unveils today, at its Annual and Special Meeting of Shareholders, a strategy to become a global on-site dross processor delivering zero-landfill/reduced carbon, and further underscored how DROSRITE™ reduces greenhouse gas (GHG) emissions.The Company is pleased to provide additional information with respect to this strategy as well as a general DROSRITE™ update in the following Q&A format.Q. Before we jump into the essence of your announcement, could you once...

Continue reading

“Grindeks” Group strategy has identified four development directions

“Grindeks” Group strategy has identified four development directions   JSC “Grindeks” informs of identifying four major strategy development directions of Group’s strategy until 2025:1) range increase of the active pharmaceutical ingredients and the final dosage forms;2) expansion in the new markets – European Union countries, US, Japan, South Korea, Australia and New Zealand;3) enlargement of the manufacturing infrastructure in Latvia;4) development of the subsidiary JSC “Kalceks”.JSC “Grindeks” strategy assumes the company to continue the focus on expanding the product range of cardiovascular, central nervous system, oncology and diabetes medications. It is expected, that in 2025 product range of mentioned therapeutic groups will consist of 105 final dosage form units, which will be exported to 97 countries around the world. To strengthen...

Continue reading

“Grindeks” koncerna stratēģija paredz četrus attīstības virzienus

“Grindeks” koncerna stratēģija paredz četrus attīstības virzienusAkciju sabiedrība “Grindeks” informē, ka ir izstrādājusi “Grindeks” koncerna attīstības stratēģiju līdz 2025. gadam, izvirzot šādus nozīmīgākos attīstības virzienus:1) jaunu aktīvo farmaceitisko vielu un gatavo zāļu formu klāsta paplašināšana;2) darbības paplašināšana jaunos tirgos – Eiropas Savienības valstīs, ASV, Japānā, Dienvidkorejā, Austrālijā un Jaunzēlandē;3) ražošanas infrastruktūras paplašināšana Latvijā;4) meitas uzņēmuma AS “Kalceks” attīstība.AS “Grindeks” stratēģija paredz, ka uzņēmums turpmāk fokusēsies uz sirds un asinsvadu, centrālo nervu sistēmu ietekmējošo, pretvēža un diabēta ārstēšanas medikamentu klāsta paplašināšanu. Plānots, ka 2025. gadā produktu klāstu šajās terapeitiskajās grupās veidos 105 gatavo zāļu formas, un tās tiks eksportētas uz 97 pasaules...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.